Earnings Per Share

EPS - Discontinued Operations (Diluted)

Over 4 years (FY 2021 to FY 2025), EPS - Discontinued Operations (Diluted) shows an upward trend with a -100.0% CAGR.

Analysis

StatementIncome Statement
SectionEarnings Per Share
First reportedQ1 2013
Last reportedQ1 2026May 5, 2026
Metric ID: ms_eps_discontinued_operations_diluted

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value-$0.04$0.00-$0.04$0.00$0.01$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
QoQ Change+100.0%+100.0%-100.0%
YoY Change+125.0%+100.0%-100.0%
Range-$0.04$0.01
CAGR-100.0%
Avg YoY Growth+41.7%
Median YoY Growth+100.0%

Frequently Asked Questions

What is Pfizer's eps - discontinued operations (diluted)?
Pfizer (PFE) reported eps - discontinued operations (diluted) of $0.00 in Q1 2026.
What is the long-term trend for Pfizer's eps - discontinued operations (diluted)?
Over 4 years (2021 to 2025), Pfizer's eps - discontinued operations (diluted) has grown at a -100.0% compound annual growth rate (CAGR), from -$0.08 to $0.00.